Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
34.17
-1.14 (-3.23%)
At close: Jul 2, 2024, 4:00 PM
34.16
-0.01 (-0.03%)
After-hours: Jul 2, 2024, 7:05 PM EDT
BHVN Employees
Biohaven Pharmaceutical Holding Company had 239 employees as of December 31, 2023. The number of employees increased by 37 or 18.32% compared to the previous year.
Employees
239
Change (1Y)
37
Growth (1Y)
18.32%
Revenue / Employee
n/a
Profits / Employee
-$2,163,933
Market Cap
3.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 239 | 37 | 18.32% |
Dec 31, 2022 | 202 | 12 | 6.32% |
Dec 31, 2021 | 190 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
Surgery Partners | 13,500 |
LivaNova | 2,900 |
Oscar Health | 2,400 |
HUTCHMED (China) | 1,988 |
Olink Holding AB (publ) | 707 |
PROCEPT BioRobotics | 626 |
Arrowhead Pharmaceuticals | 525 |
BHVN News
- 4 weeks ago - Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day - PRNewsWire
- 4 weeks ago - Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PRNewsWire
- 7 weeks ago - Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments - PRNewsWire
- 2 months ago - Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 2 months ago - Biohaven Announces Pricing of $230 Million Public Offering of Common Shares - PRNewsWire
- 2 months ago - Biohaven Announces Proposed Public Offering of Common Shares - PRNewsWire
- 2 months ago - Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates - PRNewsWire
- 4 months ago - Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments - PRNewsWire